taurine has been researched along with Acute Brain Injuries in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objectives of this study were to investigate whether taurine (Tau) can prevent d-galactose-induced cognitive dysfunction and brain oxidative damage." | 7.88 | Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage. ( Chang, YL; Chang, YY; Chen, YC; Chiang, CC; Chou, CH; Lin, YL; Tu, DG, 2018) |
| " The objectives of this study were to investigate whether taurine (Tau) can prevent d-galactose-induced cognitive dysfunction and brain oxidative damage." | 3.88 | Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage. ( Chang, YL; Chang, YY; Chen, YC; Chiang, CC; Chou, CH; Lin, YL; Tu, DG, 2018) |
| " The decreased levels of taurine, hypoxanthine, and xanthine may reflect reduced posttraumatic brain edema, whereas the increased level of glutamate could account for the elevated water content observed in the nontraumatized hemisphere." | 3.70 | Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats. ( Dohse, NK; Stover, JF; Unterberg, AW, 2000) |
| "Taurine is an abundant amino acid in the nervous system, which has been proved to possess antioxidation, osmoregulation and membrane stabilization." | 1.43 | Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats. ( Hao, YJ; Li, YX; Ma, PS; Niu, Y; Sun, T; Wu, W; Yu, JQ; Zhou, R; Zhu, XY, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C | 3 |
| He, P | 3 |
| Guo, Y | 3 |
| Tian, Q | 3 |
| Wang, J | 3 |
| Wang, G | 3 |
| Zhang, Z | 3 |
| Li, M | 3 |
| Tu, DG | 1 |
| Chang, YL | 1 |
| Chou, CH | 1 |
| Lin, YL | 1 |
| Chiang, CC | 1 |
| Chang, YY | 1 |
| Chen, YC | 1 |
| Owoeye, O | 1 |
| Adedara, IA | 1 |
| Farombi, EO | 1 |
| El-Maraghi, EF | 1 |
| Abdel-Fattah, KI | 1 |
| Soliman, SM | 1 |
| El-Sayed, WM | 1 |
| Heidari, R | 1 |
| Su, Y | 1 |
| Fan, W | 1 |
| Ma, Z | 1 |
| Wen, X | 1 |
| Wang, W | 1 |
| Wu, Q | 1 |
| Huang, H | 1 |
| Zhu, XY | 1 |
| Ma, PS | 1 |
| Wu, W | 1 |
| Zhou, R | 1 |
| Hao, YJ | 1 |
| Niu, Y | 1 |
| Sun, T | 1 |
| Li, YX | 1 |
| Yu, JQ | 1 |
| Zahr, NM | 1 |
| Mayer, D | 1 |
| Rohlfing, T | 1 |
| Hasak, MP | 1 |
| Hsu, O | 1 |
| Vinco, S | 1 |
| Orduna, J | 1 |
| Luong, R | 1 |
| Sullivan, EV | 1 |
| Pfefferbaum, A | 1 |
| Li, XQ | 2 |
| Hou, RL | 1 |
| Cheng, Y | 1 |
| Li, DL | 2 |
| Li, XJ | 1 |
| Li, S | 1 |
| Wei, LY | 1 |
| Schuhmann, MU | 2 |
| Stiller, D | 2 |
| Skardelly, M | 2 |
| Thomas, S | 1 |
| Samii, M | 2 |
| Brinker, T | 2 |
| Bernarding, J | 1 |
| Klinge, PM | 1 |
| Samii, A | 1 |
| Seki, Y | 1 |
| Kimura, M | 1 |
| Mizutani, N | 1 |
| Fujita, M | 1 |
| Aimi, Y | 1 |
| Suzuki, Y | 1 |
| Stuckey, DJ | 1 |
| Anthony, DC | 1 |
| Lowe, JP | 1 |
| Miller, J | 1 |
| Palm, WM | 1 |
| Styles, P | 1 |
| Perry, VH | 1 |
| Blamire, AM | 1 |
| Sibson, NR | 1 |
| Kimelberg, HK | 1 |
| Mongin, AA | 1 |
| Stover, JF | 4 |
| Morganti-Kosmann, MC | 1 |
| Lenzlinger, PM | 1 |
| Stocker, R | 1 |
| Kempski, OS | 1 |
| Kossmann, T | 1 |
| Dohse, NK | 1 |
| Unterberg, AW | 3 |
| Beyer, TF | 1 |
| Hashimoto-Kitsukawa, S | 1 |
| Okuyama, S | 1 |
| Aihara, H | 1 |
2 reviews available for taurine and Acute Brain Injuries
| Article | Year |
|---|---|
Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy.
Topics: Animals; Brain; Brain Injuries; Energy Metabolism; Hepatic Encephalopathy; Humans; Hyperammonemia; M | 2019 |
Swelling-activated release of excitatory amino acids in the brain: relevance for pathophysiology.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfo | 1998 |
18 other studies available for taurine and Acute Brain Injuries
| Article | Year |
|---|---|
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Taurine attenuates neuronal ferroptosis by regulating GABA
Topics: beta Catenin; Brain Injuries; Ferroptosis; gamma-Aminobutyric Acid; Glycogen Synthase Kinase 3 beta; | 2022 |
Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage.
Topics: Animals; Brain Injuries; Cognitive Dysfunction; Galactose; Glial Fibrillary Acidic Protein; Glycatio | 2018 |
Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats.
Topics: Acetylcholinesterase; Animals; Antineoplastic Agents; Antioxidants; Body Weight; Brain; Brain Injuri | 2018 |
Taurine provides a time-dependent amelioration of the brain damage induced by γ-irradiation in rats.
Topics: Animals; Brain; Brain Injuries; Gamma Rays; Male; Neuroprotective Agents; Radiation Injuries; Radiat | 2018 |
Taurine improves functional and histological outcomes and reduces inflammation in traumatic brain injury.
Topics: Animals; Brain Injuries; Disease Models, Animal; Fluorescent Antibody Technique; Inflammation; Male; | 2014 |
Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats.
Topics: Animals; Animals, Newborn; Apoptosis Inducing Factor; Brain Infarction; Brain Injuries; Female; Glut | 2016 |
Brain injury and recovery following binge ethanol: evidence from in vivo magnetic resonance spectroscopy.
Topics: Alcoholism; Analysis of Variance; Animals; Aspartic Acid; Body Weight; Brain Injuries; Brain Mapping | 2010 |
[Protective effects of taurine on rats traumatic brain injury].
Topics: Animals; Brain Injuries; Cerebral Cortex; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Superox | 2010 |
[Effects of taurine on the ultrastructure and P2X7 receptor expression in brain following traumatic brain injury in rats].
Topics: Animals; Brain; Brain Injuries; Male; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Taurin | 2012 |
Long-time in-vivo metabolic monitoring following experimental brain contusion using proton magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Basal Ganglia; Biomarkers; Brain; Brain Injuries; Disease Models, Animal; Fu | 2002 |
Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study.
Topics: Animals; Aspartic Acid; Biomarkers; Brain Injuries; Choline; Creatine; Functional Laterality; Glutam | 2003 |
Cerebrospinal fluid taurine after traumatic brain injury.
Topics: Adolescent; Adult; Aged; Brain Injuries; Humans; Linear Models; Male; Middle Aged; Multivariate Anal | 2005 |
Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy.
Topics: Amino Acids; Animals; Biomarkers; Brain Injuries; Cell Communication; Cell Extracts; Cell Line; Cell | 2005 |
Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Brain Concussion; Brain Edema; Brain Injuries; Cerebr | 1999 |
Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats.
Topics: Analysis of Variance; Animals; Body Water; Bradykinin Receptor Antagonists; Brain Chemistry; Brain E | 2000 |
Increased cerebrospinal fluid glutamate and taurine concentrations are associated with traumatic brain edema formation in rats.
Topics: Amino Acids; Animals; Body Water; Brain; Brain Edema; Brain Injuries; Glutamic Acid; Male; Osmolar C | 2000 |
Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury.
Topics: Animals; Body Water; Brain; Brain Edema; Brain Injuries; Cerebral Cortex; Glutamic Acid; Hypoxanthin | 2000 |
Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system.
Topics: Animals; Behavior, Animal; Brain Chemistry; Brain Injuries; Caudate Nucleus; Corpus Striatum; Dopami | 1988 |